Ophthotech Corporation Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (18)

Latest Posts

About This Stock More About This Stock
Ophthotech Corp Appoints New CFO And COO
Article By: KKD Healthcare Analytics
Wednesday, February 1, 2017 2:21 PM EDT
Ophthotech Corp reported it is looking at strategic alternatives for maximizing returns to its shareholders.
In this article: OPHT
Read
The FDA: Small-Cap Catalyst Or Small-Cap Killer?
Article By: Wall Street Daily
Friday, December 16, 2016 9:37 AM EDT
This particular bureaucracy neither gives nor takes. Data do. If a drug works, the company that develops it will do well. If a drug doesn’t work, the company that develops it had better have a diversified pipeline.
In this article: BMY, LLY, MRK, PFE, AMGN, CORT, VYGR, SRPT, VCEL, AKAO, CERC, PRTO, OPHT
Read
Biotechs Mixed Hurt By Alexion And Ophthotech
Article By: Rod Raynovich
Monday, December 12, 2016 11:03 PM EDT
Alexion - Company Fired its CEO and CFO on Sales Practices. Board member David Brennan and former CEO of AstraZeneca will take the helm. The third quarter report has been delayed on accounting issues and will be filed by mid - January.
In this article: LMT, NVS, ALXN, ARRY, IBB, REGN, AMGN, GILD, XBI, XLV, ABBV, BLUE, OPHT
Read
Before The Move: Ophthotech Worries Seen As Opportunity Ahead Of Phase 3 Data
Article By: The Fly
Tuesday, October 4, 2016 2:29 PM EDT
Regeneron Pharmaceuticals' disappointing Phase 2 data evaluating aflibercept co-formulated with rinucumab in neovascular age-related macular degeneration, or AMD, released on Friday have been a drag on shares of Ophthotech.
In this article: REGN, OPHT
Read
Top Stock Stories For Friday, Sept. 30
Article By: The Fly
Friday, September 30, 2016 8:32 PM EDT
Stocks on Wall Street regained the losses they'd suffered yesterday as the market reassessed whether the problems faced by Deutsche Bank are serious enough to warrant the stock's recent decline.
In this article: DB, LXK, RHHBY, REGN, CAMP, PTCT, OPHT, NTNX
Read

PARTNER HEADLINES

Latest Tweets for $OPHT

No tweets yet!